結石破砕装置の世界市場-2023年～2030年

概要

結石破砕装置は、腎臓、尿管、膀胱などの尿路のさまざまな部位に形成された結石または結石塊を破壊し、破砕することを目的とした非侵襲的な医療処置である結石破砕を実施するために、泌尿器科および腎臓内科で使用される医療機器または機械です。

結石破砕装置は、結石破砕技術の調査や医療従事者への使用方法の教育など、研究やトレーニングの場において不可欠な装置であり、患者ケアや医療行為の改善におけるその汎用性を強調しています。

結石破砕装置市場は、技術の進歩と尿路結石症やその他の尿路疾患の症例増加の結果、近年大きく成長しています。

市場促進要因：市場抑制要因

結石破砕装置の継続的な進歩

結石破砕装置市場は、継続的な技術改良によって市場を牽引すると予想されます。こうした新興国市場の開拓は、泌尿器科と腎臓内科の分野を変革し、結石破砕手技の有効性と安全性を向上させ、市場成長の原動力となっています。

例えば、2022年2月、Applaud Medical社は、同社のAcoustic Enhancer技術についてFDAからBreakthrough Device Designationを取得しました。この技術革新は、尿管鏡とレーザー結石破砕術（URS-LL）との併用により、6mmから20mmのカルシウムベースの腎結石を破砕することを目的としています。アコースティック・エンハンサーは、ガスで満たされた小さな気泡で、この目的のために特別に設計された脂質シェルで覆われています。

さらに2021年2月、米国食品医薬品局（FDA）は、高度に石灰化した冠動脈プラークの治療用としてShockwave intravascular lithotripsy（IVL）システムを承認しました。この装置は、ステント挿入を改善するために石灰化したプラークを選択的に破壊することを主な目的として、軟部動脈組織を通過可能な音波圧力波をバルーンを用いて提供します。

さらに、尿路結石症や尿路疾患の有病率の増加、人口の高齢化は、予測期間中に世界の結石破砕装置市場を牽引すると予想されるその他の主な要因の一部です。

市場力学：市場抑制要因

結石破砕装置に関連する高コストは、特に医療保険へのアクセスが限られている新興諸国において、この市場の大きな抑制要因となっています。例えば、Australian Institute of Health and Welfare 2023の記事によると、胆管結石の結石破砕術の平均費用は2,100～3,300ドルです。

さらに、結石破砕術に伴う副作用や合併症は、痛み、あざ、腎損傷のリスクを引き起こし、結石除去のための代替治療法が利用可能であることが、予測期間中の市場を抑制する要因となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 結石破砕装置の絶え間ない進歩
  • 抑制要因
    • 結石破砕装置に関連する高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMI意見

第6章 COVID-19分析

第7章 タイプ別

• 体外衝撃波結石破砕装置
• 体外衝撃波結石破砕装置
  • レーザー結石破砕装置
  • 電気水圧結石破砕装置
  • 超音波結石破砕装置
  • 機械的結石破砕装置
  • 空気圧結石破砕装置

第8章 用途別

• 腎結石
• 尿管結石
• 膵臓結石
• 胆管結石

第9章 エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Olympus Corporation
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Boston Scientific Corporation
• NOVAMEDTEK
• Inceler Medikal Co. Ltd.
• EDAP TMS
• Advin Health Care
• MTS Medical
• STORZ MEDICAL AG
• Shenzhen Huikang Medical Apparatus Co., Ltd.
• Medispec

第13章 付録

Overview

Lithotripsy devices are medical devices or machines used in urology and nephrology for carrying out lithotripsy, a non-invasive medical procedure intended to break down and fragment stones or calculi that form in different areas of the urinary tract, such as the kidneys, ureter, or bladder.

Lithotripsy devices serve as essential devices in research and training settings for examining stone fragmentation techniques and educating healthcare professionals on their use, emphasizing their versatility in improving patient care and medical practice.

The lithotripsy devices market has grown significantly in recent years as a result of technological advancements and an increase in cases of urolithiasis and other urinary tract diseases.

Market Dynamics: Drivers and Restraints

The continuous advancements in lithotripsy devices

The lithotripsy devices market is expected to drive the market owing to the ongoing technological improvements. These developments are transforming the fields of urology and nephrology, improving the efficacy and safety of lithotripsy procedures, and driving market growth.

For instance, in February 2022, Applaud Medical obtained a Breakthrough Device Designation from the FDA for its Acoustic Enhancer technology. This innovation is intended to be used in combination with ureteroscopy with laser lithotripsy (URS-LL) to break down calcium-based kidney stones ranging in size from 6 mm to 20 mm. The Acoustic Enhancer is a small bubble filled with gas and covered by a lipid shell that has been specially designed for this purpose.

Furthermore, in February 2021, The US Food and Drug Administration (FDA) has approved the Shockwave intravascular lithotripsy (IVL) system for the treatment of highly calcified coronary arterial plaques. This device uses a balloon to provide sonic pressure waves capable of passing through soft artery tissue, with the main objective of selectively breaking down calcified plaque to improve stent insertion.

Furthermore, the increasing prevalence of urolithiasis and urinary tract disorders and aging population are some of the other major factors that are expected to drive the global lithotripsy devices market over the forecast period.

Market Dynamics: Restraint

The high cost associated with the lithotripsy devices is major restraint for this market, especially in developing countries with limited access to healthcare insurance. For instance, according to Australian Institute of Health and Welfare 2023 article, the average cost of lithotripsy of bile duct stones may range within $2,100-3,300.

Furthermore, the side effects and complications associated with the lithotripsy procedures causing pain, bruising, and the risk of renal injury and and the availability of alternative treatments for stone removal are the factors that will restrain the market over the forecast period.

Segment Analysis

The global lithotripsy devices is segmented based on type, application, end user and region.

The extracorporeal shock wave lithotripsy devices segment accounted for approximately 54.2 % of the market share

The extracorporeal shock wave lithotripsy devices segment accounted for 54.2% and it is expected to be dominated during the forecast period. Extracorporeal shock wave lithotripsy is a technique that uses a lithotripter to produce a series of shock waves to break up stones in the urinary system, bile ducts, or pancreatic ducts. The segment is expected to drive owing to the increasing centers for lithotripsy and rising prevalence of kidney stones where extracorporeal shock wave lithotripsy devices play a major role.

For instance, in May 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.

Furthermore, the rising prevalence of kidney stones is major driving factors for this segment. For instance, according to National Kidney Foundation article, approximately one in ten people is expected to have kidney stone at some stage of their life. Moreover, more than one million people go the emergency rooms for kidney stone every year. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of kidney disease, product approvals, rising geriatric population, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, Adventist Health Hanford invested about USD 250,000 in November 2022 to acquire the Lumenis Pulse 120H Holmium Laser System with MOSES Technology. This cutting-edge device not only allows for speedier surgeries, saving up to 20% of the time, but it also decreases anesthetic usage, promotes faster patient recovery, and allows for outpatient treatment without hospitalization.

Furthermore, according to the Centers for Disease Control and Prevention, around 37 million people, or one in every seven adults or 15% of the adult population, were expected to have chronic renal disease by July 2022. As the prevalence of kidney disease rises, more than 50,000 lithotripsy treatments are conducted in the U.S. each year, contributing to the growth of the lithotripsy device market over the forecast period.

COVID-19 Impact Analysis

The lithotripsy device market is expected to face a setback as a result of the COVID-19 outbreak. When the pandemic occurred, the growth of the lithotripsy device industry halted. Surgical operations and non-urgent medical treatments unrelated to COVID-19 were placed on hold or canceled for the time being.

For instance, Kidney Care UK provided data in March 2021 indicating that the National Health Service (NHS) disrupted the care of more than 56% of patients. Furthermore, the report indicated that more than 28% of patients were waiting for procedures and were unable to acquire basic appointments. Furthermore, more than 18% of patients experienced difficulty reaching their general practitioners or hospital teams for medical consultations, and more than 7% reported worsening health as a result of delayed care. However, the market is expected to be stable and grow over the period of time as the resumption of all services occurs.

Competitive Landscape

The major global players in the lithotripsy devices market include: Olympus Corporation, Boston Scientific Corporation, NOVAMEDTEK, Inceler Medikal Co. Ltd., EDAP TMS, Advin Health Care, MTS Medical, STORZ MEDICAL AG, Shenzhen Huikang Medical Apparatus Co., Ltd., Medispec and among others.

Key Developments

• In May 2, 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.
• In March 31, 2022, Shockwave Medical, Inc., a pioneer in the advancement of Intravascular Lithotripsy (IVL) for treating severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter following CE Mark and FDA clearance. The Shockwave M5 + catheter, which has only recently been available, is specifically developed to reduce IVL treatment time, provide alternate access options, and expand IVL therapy to patients with larger vessel diameters.

Why Purchase the Report?

• To visualize the global lithotripsy devices market segmentation-based on type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of lithotripsy devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global lithotripsy market report would provide approximately 77 tables, 77 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. The continuous advancements in lithotripsy devices
  • 4.1.2. Restraints
    • 4.1.2.1. The high cost associated with the lithotripsy devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Extracorporeal Shock Wave Lithotripsy Devices*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Intracorporeal Lithotripsy Devices
  • 7.3.1.1. Laser Lithotripsy Devices
  • 7.3.1.2. Electrohydraulic Lithotripsy Devices
  • 7.3.1.3. Ultrasonic Lithotripsy Devices
  • 7.3.1.4. Mechanical Lithotripsy Devices
  • 7.3.1.5. Pneumatic Lithotripsy Devices

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Kidney Stones*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ureteral Stones
• 8.4. Pancreatic Stones
• 8.5. Bile Duct Stones

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Specialty Clinics
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Olympus Corporation*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Boston Scientific Corporation
• 12.3. NOVAMEDTEK
• 12.4. Inceler Medikal Co. Ltd.
• 12.5. EDAP TMS
• 12.6. Advin Health Care
• 12.7. MTS Medical
• 12.8. STORZ MEDICAL AG
• 12.9. Shenzhen Huikang Medical Apparatus Co., Ltd.
• 12.10. Medispec

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us